Pacific Biosciences is trading 5.3% down today at $1.52 after investors reacted to the sudden resignation of board member Christopher M. Smith, announced on July 9, 2026.
- The company stated the departure was amicable and not related to any internal disputes, though the loss of a veteran diagnostics and genomics executive appears to be weighing on investor sentiment.
- The stock's decline stands in contrast to the broader markets, which are currently trading slightly higher.